Illustrative image – not actual.The National Dairy Development Board
(NDDB), Anand, is setting up a human vaccines plant and research and
development (R&D) centre at Hyderabad through its wholly-owned subsidiary
Indian Immunologicals (IIL).
The new the Rs.42 crore plant has
been designed to manufacture various human vaccines for Recombiant Hepatitis B,
Hepatitis A, Measles, Diphtheria, Pertussis and Tetanus. The plant will have a capacity
to produce 200 million doses a year of each vaccine.
Along with the manufacturing unit, a
research and development centre with an investment of Rs.8 crore is also being
set up.
